Constructing small-caliber anticoagulant vascular grafts using decellularized scaffolds with heparin immobilization

Zhou Min,Liu Chang-jian,Wei Zhi-qing,Qiao Wei,Qiao Tong,Ran Feng,Zhang Ming
2008-01-01
Abstract:BACKGROUND: The small-caliber vascular grafts with diameter less than 6 mm can not achieve good effect for its poor biocompatibility and low graft patency. OBJECTIVE: To design a novel small-caliber vascular graft through heparin immobilization to the decellularized vascular scaffolds. DESIGN, TIME AND SETTING: The in vitro histopathology observation was performed in the Laboratory of Drum Tower Hospital from September 2005 to September 2007. MATERIALS: Six adult mongrel dogs, weighing 20 kg and irrespective of genders,were adopted. METHODS: The decellularized canine common carotid arteries were treated by detergent enzyme extraction, and covalently linked with heparin. Heparin-treated grafts and acellular matrix were implanted to carotid artery for allograft vasotransplantation experiment. MAIN OUTCOME MEASURES: Biocompatibility and blood compatibility of vascular grafts were evaluated by platelet adhesion test and cytotoxicity experiment, and the early thrombosis was assessed by allograft vasotransplantation experiment. RESULTS: Cellular components was completely removed and the extracellular matrix structure was intact remained. The decellularized-heparin-treated grafts has excellent antithrombogeneity and no cytotoxicity. Decellularized-heparin-treated grafts remained patent 1 month after implantation, while the non-heparin immobilized decellularized grafts were occluded as thrombosis. CONCLUSION: Decellularized scaffolds with heparin immobilization can be used to construct small caliber vascular grafts. The decellularized -heparin-treated grafts has excellent biocompatibility and blood compatibility.
What problem does this paper attempt to address?